Skip to main content
Swing Capital

Sumitomo Chemical India Ltd

NSE: SUMICHEM BSE: 542920Pharma

Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.[1] [2]

₹449
52W: ₹363 — ₹665
PE 41.4 · Book ₹64 · +602% vs book
Market Cap₹22,424 Cr
Stock P/E41.4Price to Earnings
ROCE25.1%Return on Capital
ROE18.8%Return on Equity
Div. Yield0.26%Face Value ₹10

Strengths

  • +Company is almost debt free.
  • +Company has been maintaining a healthy dividend payout of 34.5%

Weaknesses

  • −The company has delivered a poor sales growth of 4.98% over past five years.

Shareholding Pattern

Promoters75%
FIIs3.41%
DIIs8.98%
Public12.6%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters75%75%75%75%75%75%75%75%
FIIs3.06%3.49%▲0.43.59%▲0.13.63%▲0.03.65%▲0.03.65%3.37%▼0.33.41%▲0.0
DIIs7.13%6.96%▼0.26.96%8.13%▲1.28.15%▲0.08.47%▲0.38.65%▲0.28.98%▲0.3
Public14.79%14.54%▼0.314.44%▼0.113.23%▼1.213.19%▼0.012.88%▼0.312.97%▲0.112.6%▼0.4

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales9035406648329716226651,048914552
Expenses715474526670729521548828697456
Operating Profit1886613916224210111722021796
OPM %21%12%21%19%25%16%18%21%24%17%
Net Profit14455109128191849818017875
EPS ₹2.881.12.192.573.821.691.973.63.561.5

AI Insights

Revenue Trend

TTM revenue at ₹3,179Cr, up 2.9% YoY. OPM at 20%.

Debt Position

Borrowings at ₹49Cr. Debt-to-equity ratio: 0.02x. Healthy balance sheet.

Capex Cycle

CWIP at ₹14Cr (3% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 8.98% (+3.48pp change). FIIs: 3.41% (+0.90pp change). Promoters hold 75%.

Margin & Efficiency

ROCE improving from 25% (Mar 2014) to 25% (Mar 2025). Working capital days: 183.

Valuation

PE 41.4x with 25.1% ROCE. Price is 602% above book value of ₹64. Dividend yield: 0.26%.

Recent Announcements